Home The Word Brain	My Amedeo FAQ Privacy About
	As of October 2023, Amedeo had 12,263 active subscribers

Pulmonary Hypertension, June 2023 Free Subscription Abstracts Retrieve all available abstracts of the following 144 articles: HTML format

Single Articles

1. SULLERE V, Sullere S, Khan IA, Goyal RG, et al
   Pulmonary Hypertension, an Echo Assessment: Is it Arterial or Venous?
   Int J Appl Basic Med Res. 2023;13:29-39.
   PubMed    
   Abstract available
   
   

2. WIETESKA-MILEK M, Kusmierczyk-Droszcz B, Betkier-Lipinska K, Szmit S, et al
   Long COVID syndrome after SARS-CoV-2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
   Pulm Circ. 2023;13:e12244.
   PubMed    
   Abstract available
   
   

3. OTERO R, Lobo JL, Lopez R, Fernandez C, et al
   Feasibility of a screening algorithm for chronic thromboembolic pulmonary hypertension: The OSIRIS study.
   Thromb Res. 2023;228:1-9.
   PubMed    
   Abstract available
   
   

4. KLOUDA T, Tsikis ST, Kim H, Liu T, et al
   Pericytes Contribute to Flow-induced Pulmonary Hypertension.
   Am J Respir Cell Mol Biol. 2023;68:705-708.
   PubMed    
   
   
   

5. BRANESCU I, Shetty S, Richards J, Vladareanu S, et al
   Pulmonary Hypertension in Preterm Infants with Moderate to Severe Bronchopulmonary Dysplasia (BPD).
   Acta Paediatr. 2023 Jun 1. doi: 10.1111/apa.16863.
   PubMed    
   Abstract available
   
   

6. GURDOGAN M, Demir M, Yalta K, Gulertop Y, et al
   Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice.
   Anatol J Cardiol. 2023;27:299-307.
   PubMed    
   Abstract available
   
   

7. TANYERI S, Tokgoz HC, Karagoz A, Akbal OY, et al
   Reappraisal of the Transthoracic Echocardiographic Algorithm in Predicting Pulmonary Hypertension Redefined by Updated Pulmonary Artery Mean Pressure Threshold.
   Anatol J Cardiol. 2023;27:348-359.
   PubMed    
   Abstract available
   
   

8. SCHULZE KM, Musch TI
   Skeletal muscle blood flow during exercise is reduced in a rat model of pulmonary hypertension.
   Am J Physiol Regul Integr Comp Physiol. 2023;324:R772-R773.
   PubMed    
   
   
   

9. MORRIS HE, Neves KB, Nilsen M, Montezano AC, et al
   Notch3/Hes5 Induces Vascular Dysfunction in Hypoxia-Induced Pulmonary Hypertension Through ER Stress and Redox-Sensitive Pathways.
   Hypertension. 2023 May 31. doi: 10.1161/HYPERTENSIONAHA.122.20449.
   PubMed    
   Abstract available
   
   

10. ADARE OE, Seife MA, Abate LG
    Perioperative Anesthesia Management for Pregnant Mother with Multivalvular Heart Disease and Moderate Pulmonary Hypertension Who Underwent Caesarean Section, in Resource Limiting Area 2022: A Case Report.
    Int Med Case Rep J. 2023;16:311-317.
    PubMed    
    Abstract available
    
    

11. OLIYNYK OV, Rorat M, Strepetova OV, Dubrov SO, et al
    Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension.
    Viruses. 2023;15:1157.
    PubMed    
    Abstract available
    
    

12. IZUMIDA T, Imamura T, Ushijima R, Kinugawa K, et al
    Combination Treatment of Balloon Pulmonary Angioplasty and Direct Oral Anticoagulant in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated by Protein S Deficiency.
    Medicina (Kaunas). 2023;59:909.
    PubMed    
    Abstract available
    
    

13. KARYOFYLLIS P, Demerouti E, Habibis P, Apostolopoulou S, et al
    Should We Change the Target of Therapy in Pulmonary Hypertension?
    Life (Basel). 2023;13:1202.
    PubMed    
    Abstract available
    
    

14. NOVOYATLEVA T
    Pulmonary Hypertension: New Insights and Recent Advances from Basic Science to Translational Approaches.
    Int J Mol Sci. 2023;24:8462.
    PubMed    
    Abstract available
    
    

15. MAMAZHAKYPOV A, Maripov A, Sarybaev AS, Schermuly RT, et al
    Osteopontin in Pulmonary Hypertension.
    Biomedicines. 2023;11:1385.
    PubMed    
    Abstract available
    
    

16. POYATOS P, Gratacos M, Samuel K, Orriols R, et al
    Oxidative Stress and Antioxidant Therapy in Pulmonary Hypertension.
    Antioxidants (Basel). 2023;12:1006.
    PubMed    
    Abstract available
    
    

17. ZHANG J, Zhang S, Xu S, Zhang X, et al
    Pulmonary Arterial Hypertension Induced by Immune Checkpoint Inhibitor Combined Therapy in a Patient with Intrahepatic Cholangiocarcinoma: A Case Report.
    Iran J Immunol. 2023;20:240-246.
    PubMed    
    Abstract available
    
    

18. KUMAR M, Zaman MK, Das S, Goyary D, et al
    Transient Receptor Potential Vanilloid (TRPV4) channel inhibition: A novel promising approach for the treatment of lung diseases.
    Biomed Pharmacother. 2023;163:114861.
    PubMed    
    Abstract available
    
    

19. REICHMANN J, Verleden SE, Kuhnel M, Kamp JC, et al
    Human lung virtual histology by multi-scale x-ray phase-contrast computed tomography.
    Phys Med Biol. 2023;68.
    PubMed    
    Abstract available
    
    

20. MIRHADI E, Kesharwani P, Johnston TP, Sahebkar A, et al
    Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension.
    Drug Discov Today. 2023;28:103599.
    PubMed    
    Abstract available
    
    

21. GALLOO X, Dietz MF, Fortuni F, Prihadi EA, et al
    Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation.
    Eur Heart J Cardiovasc Imaging. 2023;24:733-741.
    PubMed    
    Abstract available
    
    

22. CRUZ-UTRILLA A, Gallego-Zazo N, Perez-Olivares C, Hernandez-Gonzalez I, et al
    Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension.
    Rev Esp Cardiol (Engl Ed). 2023;76:460-467.
    PubMed    
    Abstract available
    
    

23. LU VM, Leuchter JD, Clarke JE, Luther EM, et al
    The utility of congenital cardiac status to predict endoscopic third ventriculostomy and ventriculoperitoneal shunt failure in hydrocephalic infants.
    J Neurosurg Pediatr. 2022 Mar 4:1-8. doi: 10.3171/2022.1.PEDS21567.
    PubMed    
    Abstract available
    
    

24. GUO Q, Lu L, Jia B, Liu Y, et al
    A Meta-analysis Assessing the Efficacy of Balloon Pulmonary Angioplasty in Resolving Chronic Thromboembolic Pulmonary Hypertension.
    Altern Ther Health Med. 2023 Jun 9:AT8717.
    PubMed    
    Abstract available
    
    

25. BORDAG N, Nagy BM, Zugner E, Ludwig H, et al
    Lipidomics for diagnosis and prognosis of pulmonary hypertension.
    medRxiv. 2023 May 24:2023.05.17.23289772. doi: 10.1101/2023.05.17.23289772.
    PubMed    
    Abstract available
    
    

26. HE S, Qian H, Xu X
    Editorial: Pulmonary hypertension associated with congenital heart disease.
    Front Pediatr. 2023;11:1217010.
    PubMed    
    
    
    

27. HOSOKAWA K, Yamasaki Y, Abe K
    Technical Considerations for Performing Safe and Effective Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    Interv Cardiol Clin. 2023;12:367-380.
    PubMed    
    Abstract available
    
    

28. WISSMULLER M, Dohr J, Adler J, Ochs L, et al
    Pulmonary hypertension associated with left heart disease.
    Herz. 2023 Jun 8. doi: 10.1007/s00059-023-05189.
    PubMed    
    Abstract available
    
    

29. ZHOU Q, Jiang J, Xu Y, Qiu H, et al
    Congenital hepatic hemangioma: an unusual case report of pulmonary hypertension.
    BMC Pediatr. 2023;23:284.
    PubMed    
    Abstract available
    
    

30. GAYEN S, Ansari S, Lashari BH, Zhao H, et al
    Pulmonary vasodilator therapy in sarcoidosis-associated pulmonary hypertension may decrease lung function decline and mortality.
    Pulm Circ. 2023;13:e12245.
    PubMed    
    Abstract available
    
    

31. ZHANG F, Huang X, Lin J, Yu R, et al
    Identification of a novel diagnosis model based on 5 hub genes for chronic thromboembolic pulmonary hypertension.
    Curr Med Chem. 2023 Jun 5. doi: 10.2174/0929867330666230605125512.
    PubMed    
    Abstract available
    
    

32. HAGIWARA H, Akatsuka M, Takahashi K, Yoshinaka A, et al
    A Patient with Class III Obesity and a Body Mass Index of 70.1 kg/m(2) Requiring Pulmonary Artery Catheterization to Confirm the Diagnosis of Pulmonary Hypertension.
    Am J Case Rep. 2023;24:e939383.
    PubMed    
    Abstract available
    
    

33. RATWATTE S, Strange G, Playford D, Stewart S, et al
    Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes.
    Open Heart. 2023;10:e002268.
    PubMed    
    Abstract available
    
    

34. LI YS, Zhang Z, Xie WM, Zhai ZG, et al
    [Advances in the epidemiology of chronic thromboembolic pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:603-609.
    PubMed    
    Abstract available
    
    

35. LIN YK, Yang DH, Lei C, Luo H, et al
    [Hereditary pulmonary hypertension family with BMPR2 gene variation: a case report and literature review].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:558-564.
    PubMed    
    Abstract available
    
    

36. ZHAI ZG, Yang YH, Wang C
    [Strengthening the construction of standardized system to enhance the standard diagnosis, treatment and comprehensive management of pulmonary hypertension in China].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:553-557.
    PubMed    
    Abstract available
    
    

37. SURGIT O, Guner A, Turkmen I, Kahraman S, et al
    Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism.
    Ulus Travma Acil Cerrahi Derg. 2023;29:677-684.
    PubMed    
    Abstract available
    
    

38. WANG L, Wang F, Tuo Y, Wan H, et al
    Correction: Clinical characteristics and predictors of pulmonary hypertension in chronic obstructive pulmonary disease at different altitudes.
    BMC Pulm Med. 2023;23:192.
    PubMed    
    
    
    

39. ORIEUX A, Samson C, Pieroni L, Drouin S, et al
    Pulmonary hypertension without heart failure causes cardiorenal syndrome in a porcine model.
    Sci Rep. 2023;13:9130.
    PubMed    
    Abstract available
    
    

40. MORALES-LARA AC, Elkhatib W, Oluleye O, Alhusain R, et al
    Impact of Pulmonary Hypertension Hemodynamic Phenotype on Incident Atrial Fibrillation.
    Cardiology. 2023 Jun 5. doi: 10.1159/000531402.
    PubMed    
    Abstract available
    
    

41. PROVOST M, Mornex JF, Nasser M, Zeghmar S, et al
    Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre.
    Respir Med Res. 2023;84:101021.
    PubMed    
    Abstract available
    
    

42. MAHMUD E, Ang L
    Percutaneous Interventional Therapy for Chronic Thromboembolic Pulmonary Hypertension.
    Struct Heart. 2022;7:100115.
    PubMed    
    Abstract available
    
    

43. TSUCHIYA N, Xu YY, Ito J, Yamashiro T, et al
    Chronic thromboembolic pulmonary hypertension is associated with a loss of total lung volume on computed tomography.
    World J Radiol. 2023;15:146-156.
    PubMed    
    Abstract available
    
    

44. ZHAO YN, Liu GH, Wang C, Zhang YX, et al
    Pulmonary hypertension, nephrotic syndrome, and polymyositis due to hepatitis C virus infection: A case report.
    World J Gastroenterol. 2023;29:3040-3047.
    PubMed    
    Abstract available
    
    

45. XU Y, Yang B, Hui J, Zhang C, et al
    The emerging role of sacubitril/valsartan in pulmonary hypertension with heart failure.
    Front Cardiovasc Med. 2023;10:1125014.
    PubMed    
    Abstract available
    
    

46. EROL N, Alpinar A, Kulcu NU
    Infantile hemangiomatosis, a rare cause of high-output heart failure and pulmonary hypertension in the newborn baby: a case report.
    Cardiol Young. 2023 Jun 5:1-3. doi: 10.1017/S1047951123001488.
    PubMed    
    Abstract available
    
    

47. LIU Y, Deng J, Zhao Y, Liu K, et al
    Outcomes of pregnancy in mice with pulmonary hypertension induced by Hypoxia/SU5416.
    Biochem Biophys Res Commun. 2023;669:128-133.
    PubMed    
    Abstract available
    
    

48. ALBINNI S, Heno J, Pavo I, Kitzmueller E, et al
    Macitentan in the Young-Mid-term Outcomes of Patients with Pulmonary Hypertensive Vascular Disease treated in a Pediatric Tertiary Care Center.
    Paediatr Drugs. 2023 Jun 3. doi: 10.1007/s40272-023-00573.
    PubMed    
    Abstract available
    
    

49. ZHANG Q, Chen Y, Wang Q, Wang Y, et al
    HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo.
    Respir Res. 2023;24:149.
    PubMed    
    Abstract available
    
    

50. HAJIAHMADI S, Tabesh F, Shayganfar A, Shirani F, et al
    Pulmonary artery obstruction index, pulmonary artery diameter and right ventricle strain as prognostic CT findings in patient with acute pulmonary embolism.
    Radiologia (Engl Ed). 2023;65:200-212.
    PubMed    
    Abstract available
    
    

51. TOBITA K, Goda A, Teruya K, Nishida Y, et al
    Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2023;12:e026890.
    PubMed    
    Abstract available
    
    

52. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    PubMed    
    Abstract available
    
    

53. XUE Z, Zhou M, Liu Y, Qin H, et al
    A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
    J Ethnopharmacol. 2023;314:116544.
    PubMed    
    Abstract available
    
    

54. COLLERAN JA, Daykin EC, Hernandez C, Ray J, et al
    Novel mosaic TRAF7 likely pathogenic variant in an African American family.
    Am J Med Genet A. 2023;191:1990-1993.
    PubMed    
    Abstract available
    
    

55. RAMARAJ AB, Rice-Townsend SE, Foster CL, Yung D, et al
    Association Between Early Prostacyclin Therapy and Extracorporeal Life Support Use in Patients With Congenital Diaphragmatic Hernia.
    JAMA Pediatr. 2023;177:582-589.
    PubMed    
    Abstract available
    
    

56. GUGLIANDOLO E, Macri F, Fusco R, Siracusa R, et al
    Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of Pulmonary Arterial Hypertension.
    Pharmacol Res. 2023;192:106750.
    PubMed    
    Abstract available
    
    

57. DE JAGER P, Curley MAQ, Cheifetz IM, Kneyber MCJ, et al
    Hemodynamic Effects of a High-Frequency Oscillatory Ventilation Open-Lung Strategy in Critically Ill Children With Acquired or Congenital Cardiac Disease.
    Pediatr Crit Care Med. 2023;24:e272-e281.
    PubMed    
    Abstract available
    
    

58. CHEN Y, Xu R, Xie X, Wang T, et al
    Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta-analysis.
    Ultrasound Obstet Gynecol. 2023 Jan 27. doi: 10.1002/uog.26164.
    PubMed    
    Abstract available
    
    

59. ISHII S, Hatano M, Maki H, Minatsuki S, et al
    Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension.
    J Cardiol. 2023;82:69-75.
    PubMed    
    Abstract available
    
    

60. DONNELLY RP, Smyth AE, Mullan C, Riley MS, et al
    Responses to exercise in systemic sclerosis-associated interstitial lung disease.
    Clin Physiol Funct Imaging. 2023;43:253-262.
    PubMed    
    Abstract available
    
    

61. DIEZ M, Caneva J, Diez A, Perna ER, et al
    Risk stratification, prognosis, and survival in a pulmonary arterial hypertension cohort in Latin America. A multicenter study.
    Respir Med Res. 2023;83:100945.
    PubMed    
    Abstract available
    
    

62. LIU W, LeBar K, Roth K, Pang J, et al
    Alterations of biaxial viscoelastic properties of the right ventricle in pulmonary hypertension development in rest and acute stress conditions.
    Front Bioeng Biotechnol. 2023;11:1182703.
    PubMed    
    Abstract available
    
    

63. QU S, Shan L, Chen X, Zhang Z, et al
    The role of rhIGF-1/BP3 in the prevention of pulmonary hypertension in bronchopulmonary dysplasia and its underlying mechanism.
    BMC Pulm Med. 2023;23:209.
    PubMed    
    Abstract available
    
    

64. ITURRIAGA R, Castillo-Galan S
    The Beneficial Effect of the Blockade of Stim-Activated TRPC-ORAI Channels on Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia Is Independent of Oxidative Stress.
    Adv Exp Med Biol. 2023;1427:53-60.
    PubMed    
    Abstract available
    
    

65. LANG IM, Delcroix M
    Novel acquisitions in chronic thromboembolic pulmonary hypertension.
    Eur Heart J. 2023 Jun 15:ehad314. doi: 10.1093.
    PubMed    
    
    
    

66. LAKSHMINRUSIMHA S, Fraga MV
    Longitudinal Trajectory of Ventricular Function and Pulmonary Hypertension in Congenital Diaphragmatic Hernia.
    J Pediatr. 2023 Jun 12:113550. doi: 10.1016/j.jpeds.2023.113550.
    PubMed    
    
    
    

67. SHI H, Chen L, Zhang S, Li R, et al
    Dynamic association of ambient air pollution with incidence and mortality of pulmonary hypertension: A multistate trajectory analysis.
    Ecotoxicol Environ Saf. 2023;262:115126.
    PubMed    
    Abstract available
    
    

68. MINATSUKI S, Hatano M, Tanikawa I, Hirose K, et al
    Verification of Optimal Balloon Size in Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Cardiovasc Intervent Radiol. 2023 Jun 13. doi: 10.1007/s00270-023-03489.
    PubMed    
    
    
    

69. IGARASHI S, Ishida Y, Sekiguchi S, Fujita Y, et al
    Evaluation of total intravenous anesthesia with remimazolam in general anesthesia for pulmonary endarterectomy of chronic thromboembolic pulmonary hypertension: a case report.
    JA Clin Rep. 2023;9:34.
    PubMed    
    Abstract available
    
    

70. AVITABILE CM, Hopper RK, Handler SS, Bates A, et al
    Editorial: Advances in the care of the pediatric pulmonary hypertension patient: from the neonate to the adolescent-young adult patient.
    Front Pediatr. 2023;11:1220070.
    PubMed    
    
    
    

71. NAKAYAMA H, Ishida M, Nakaoka H, Nishimura Y, et al
    Pulmonary hypertension secondary to interstitial fibrosis with pulmonary venous lesions masquerading pulmonary veno-occlusive disease.
    Respirol Case Rep. 2023;11:e01179.
    PubMed    
    Abstract available
    
    

72. NAKAYAMA M, Konishi M, Sugano T, Okamura M, et al
    Association between sarcopenia and exercise capacity in patients with pulmonary hypertension without left heart disease.
    Int J Cardiol. 2023 Jun 9:S0167-5273(23)00883.
    PubMed    
    Abstract available
    
    

73. MURNI IK, Kato T, Wirawan MT, Arafuri N, et al
    An electrocardiographic score to predict pulmonary hypertension in children with atrial septal defect.
    BMC Pediatr. 2023;23:288.
    PubMed    
    Abstract available
    
    

74. KHEYFETS VO, Kumar S, Heerdt PM, Ichimura K, et al
    Characterizing the Spatiotemporal Transcriptomic Response of the Right Ventricle to Acute Pressure Overload.
    Int J Mol Sci. 2023;24:9746.
    PubMed    
    Abstract available
    
    

75. WOLOWIEC L, Medlewska M, Osiak J, Wolowiec A, et al
    MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment.
    Int J Mol Sci. 2023;24:9735.
    PubMed    
    Abstract available
    
    

76. LUO A, Jia Y, Hao R, Yu Y, et al
    Quantitative Proteomic and Phosphoproteomic Profiling of Lung Tissues from Pulmonary Arterial Hypertension Rat Model.
    Int J Mol Sci. 2023;24:9629.
    PubMed    
    Abstract available
    
    

77. RIOU M, Enache I, Sauer F, Charles AL, et al
    Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
    Int J Mol Sci. 2023;24:9572.
    PubMed    
    Abstract available
    
    

78. KHALIL S
    Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Pediatrician's Viewpoint.
    Indian Pediatr. 2023;60:490-491.
    PubMed    
    
    
    

79. GUPTA N
    Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Neonatologist's Viewpoint.
    Indian Pediatr. 2023;60:489-490.
    PubMed    
    
    
    

80. KUMAR A, Dutta S
    Is Expectant Management Noninferior to Early Ibuprofen for Patent Ductus Arteriosus?: Evidence-based Medicine Viewpoint.
    Indian Pediatr. 2023;60:488-489.
    PubMed    
    
    
    

81. MA R, Gao H, Cui J, Shi H, et al
    Pregnancy feasibility in women with mild pulmonary arterial hypertension: a systematic review and meta-analysis.
    BMC Pregnancy Childbirth. 2023;23:427.
    PubMed    
    Abstract available
    
    

82. SURESH MV, Aggarwal V, Raghavendran K
    The Intersection of Pulmonary Vascular Disease and Hypoxia-Inducible Factors.
    Interv Cardiol Clin. 2023;12:443-452.
    PubMed    
    Abstract available
    
    

83. JAIN N, Perkins S, Maligireddy AR, Rosenfield K, et al
    Evolving Role and Clinical Evidence in the Global Practice of Balloon Pulmonary Angioplasty.
    Interv Cardiol Clin. 2023;12:417-427.
    PubMed    
    Abstract available
    
    

84. VISOVATTI SH
    Pulmonary Embolism Center of Excellence: Putting It All Together.
    Interv Cardiol Clin. 2023;12:393-398.
    PubMed    
    Abstract available
    
    

85. TANNU M, Krasuski RA
    The Evolution of Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension.
    Interv Cardiol Clin. 2023;12:381-391.
    PubMed    
    Abstract available
    
    

86. HAFT JW, Yost G
    Open Surgical Treatment of Acute and Chronic Pulmonary Embolism.
    Interv Cardiol Clin. 2023;12:339-347.
    PubMed    
    Abstract available
    
    

87. BAE JY, Murugiah K
    Invasive Pulmonary Angiogram Performance and Interpretation in the Diagnosis of Pulmonary Thromboembolic Disease.
    Interv Cardiol Clin. 2023;12:299-307.
    PubMed    
    Abstract available
    
    

88. HAMEED A, Condliffe R, Swift AJ, Alabed S, et al
    Assessment of Right Ventricular Function-a State of the Art.
    Curr Heart Fail Rep. 2023;20:194-207.
    PubMed    
    Abstract available
    
    

89. TIAN Z, Cen L
    Interaction of Biochemical Processes between Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Arterial Hypertension (PAH), and Coronavirus Disease 2019 (COVID-19).
    Pol J Microbiol. 2023;72:143-154.
    PubMed    
    Abstract available
    
    

90. KRISHNATHASAN K, Constantine A, Rafiq I, Barradas Pires A, et al
    Management of pulmonary arterial hypertension during pregnancy.
    Expert Rev Respir Med. 2023;17:413-423.
    PubMed    
    Abstract available
    
    

91. ASAKAGE A, Baekgaard J, Mebazaa A, Deniau B, et al
    Management of Acute Right Ventricular Failure.
    Curr Heart Fail Rep. 2023;20:218-229.
    PubMed    
    Abstract available
    
    

92. RAKHA S, Hammad A, Elmarsafawy H, Korkor MS, et al
    A deeper look into the functions of right ventricle using three-dimensional echocardiography: the forgotten ventricle in children with systemic lupus erythematosus.
    Eur J Pediatr. 2023;182:2807-2819.
    PubMed    
    Abstract available
    
    

93. MARTENS P, Yu S, Larive B, Borlaug BA, et al
    Iron deficiency in pulmonary vascular disease: pathophysiological and clinical implications.
    Eur Heart J. 2023;44:1979-1991.
    PubMed    
    Abstract available
    
    

94. SHEIKH REZAEI S, Gatterer C, Sulzgruber P, Hofer F, et al
    Risk stratification and long-term outcome of patients receiving in-hospital medical emergency team critical care: experience from Austria's largest medical center.
    Minerva Med. 2023;114:307-315.
    PubMed    
    Abstract available
    
    

95. LIU Z, Zhang C, Gong W, Xu J, et al
    Biological functions of miR-124/notch in pulmonary arterial hypertension.
    Minerva Med. 2023;114:404-405.
    PubMed    
    
    
    

96. ROUBENNE L, Laisne M, Benoist D, Campagnac M, et al
    OP2113, a new drug for chronic hypoxia-induced pulmonary hypertension treatment in rat.
    Br J Pharmacol. 2023 Jun 23. doi: 10.1111/bph.16174.
    PubMed    
    Abstract available
    
    

97. ZHANG H, Li QW, Li YY, Tang X, et al
    Myeloid-derived suppressor cells and pulmonary hypertension.
    Front Immunol. 2023;14:1189195.
    PubMed    
    Abstract available
    
    

98. BRALEY K, Richardson K, Whitley L, Werner K, et al
    Patient perspectives on pulmonary hypertension in the United States: Burdens, expectations, and goals.
    Pulm Circ. 2023;13:e12247.
    PubMed    
    Abstract available
    
    

99. ARKANI M, Kianzad A, Jansen S, Smit J, et al
    Discrimination Between Pre- and Postcapillary Pulmonary Hypertension Using Platelet RNA.
    J Am Heart Assoc. 2023 Jun 22:e028447. doi: 10.1161/JAHA.122.028447.
    PubMed    
    Abstract available
    
    

100. NI H, Wei Y, Yang L, Wang Q, et al
     An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis.
     BMC Pulm Med. 2023;23:221.
     PubMed    
     Abstract available
     
     

101. SU H, Zhu H, Wang S, Li Y, et al
     CircItgb5 promotes synthetic phenotype of pulmonary artery smooth muscle cells via interacting with miR-96-5p and Uba1 in monocrotaline-induced pulmonary arterial hypertension.
     Respir Res. 2023;24:165.
     PubMed    
     Abstract available
     
     

102. LI M, Plecita-Hlavata L, Dobrinskikh E, McKeon BA, et al
     SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
     Am J Respir Cell Mol Biol. 2023 Jun 21. doi: 10.1165/rcmb.2022-0360.
     PubMed    
     Abstract available
     
     

103. LEYENS J, Schroeder L, Geipel A, Berg C, et al
     Dynamics of pulmonary hypertension severity in the first 48 h in neonates with prenatally diagnosed congenital diaphragmatic hernia.
     Front Pediatr. 2023;11:1164473.
     PubMed    
     Abstract available
     
     

104. EJIRI K, Akagi S, Ito H
     Woman in Her 50s With Pulmonary Hypertension Associated With Takayasu Arteritis.
     JAMA Cardiol. 2023 Jun 21. doi: 10.1001/jamacardio.2023.1650.
     PubMed    
     
     
     

105. TEIXEIRA-FONSECA JL, Joviano-Santos JV, Beserra SS, de Lima Conceicao MR, et al
     Exploring the involvement of TASK-1 in the control of isolated rat right atrium function from healthy animals and an experimental model of monocrotaline-induced pulmonary hypertension.
     Naunyn Schmiedebergs Arch Pharmacol. 2023.
     PubMed    
     Abstract available
     
     

106. VAKHSHOORZADEH J, Lui JK, Sangani RA, Trojanowski MA, et al
     Emphysema and interstitial lung disease in systemic sclerosis-related pulmonary hypertension.
     Respir Med. 2023;216:107333.
     PubMed    
     
     
     

107. ASCHNER J, Avachat C, Birnbaum A, Sherwin C, et al
     Multi-dose enteral L-citrulline administration in premature infants at risk of developing pulmonary hypertension associated with bronchopulmonary dysplasia.
     Res Sq. 2023 Jun 9:rs.3.rs-3006963. doi: 10.21203/rs.3.rs-3006963.
     PubMed    
     Abstract available
     
     

108. AHMED A, Ahmed S, Radegran G
     Risk assessment in pulmonary arterial hypertension: A step towards clinical implementation based on the 2022 ESC/ERS pulmonary hypertension guidelines.
     Pulm Circ. 2023;13:e12253.
     PubMed    
     
     
     

109. BABU G, Annis JS, Garry JD, Freiberg MS, et al
     Clinical features do not identify risk of progression from isolated postcapillary pulmonary hypertension to combined pre- and postcapillary pulmonary hypertension.
     Pulm Circ. 2023;13:e12249.
     PubMed    
     Abstract available
     
     

110. KATOTO PDMC, Mukasa SL, Sani MU, Karaye KM, et al
     HIV status and survival of patients with pulmonary hypertension due to left heart disease: the Pan African Pulmonary Hypertension Cohort.
     Sci Rep. 2023;13:9790.
     PubMed    
     Abstract available
     
     

111. GU C, Yang Z, Su S, Ma K, et al
     4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats.
     Toxicol Appl Pharmacol. 2023;473:116596.
     PubMed    
     Abstract available
     
     

112. MORRISON AM, Huang S, Annis JS, Garry JD, et al
     Cardiometabolic Risk Factors Associated With Right Ventricular Function and Compensation in Patients Referred for Echocardiography.
     J Am Heart Assoc. 2023;12:e028936.
     PubMed    
     Abstract available
     
     

113. SHAW DE, Smith N, Beerli R, Cotesta S, et al
     Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension.
     J Med Chem. 2023;66:8130-8139.
     PubMed    
     Abstract available
     
     

114. CHEN L, Li M, Shen M, Zhu Y, et al
     Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy.
     Acta Biochim Biophys Sin (Shanghai). 2023;55:831-841.
     PubMed    
     Abstract available
     
     

115. YOSHIDA K, Axelsen JB, Saku K, Andersen A, et al
     How to incorporate tricuspid regurgitation in right ventricular-pulmonary arterial coupling.
     J Appl Physiol (1985). 2023;135:53-59.
     PubMed    
     Abstract available
     
     

116. TANG BL, Liu Y, Zhang JL, Lu ML, et al
     Ginsenoside Rg1 ameliorates hypoxia-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition and inflammation by regulating CCN1.
     Biomed Pharmacother. 2023;164:114920.
     PubMed    
     Abstract available
     
     

117. HUNSAKER AR
     Editorial Comment: Pulmonary Arterial Thrombosis Due to Embolic Events-or In Situ Thrombosis?
     AJR Am J Roentgenol. 2023;221:68.
     PubMed    
     
     
     

118. MA C, Wang X, Zhang L, Zhu X, et al
     Super Enhancer-Associated Circular RNA-CircKrt4 Regulates Hypoxic Pulmonary Artery Endothelial Cell Dysfunction in Mice.
     Arterioscler Thromb Vasc Biol. 2023;43:1179-1198.
     PubMed    
     Abstract available
     
     

119. GUPTA D, Greenberg RG, Natarajan G, Jani S, et al
     Association of patent ductus arteriosus with extubation failure among preterm infants.
     Pediatr Pulmonol. 2023 Apr 21. doi: 10.1002/ppul.26420.
     PubMed    
     Abstract available
     
     

120. BUENDIA JA, Lindarte EF, Guerrero Patino D
     Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension: A Cost-Utility Analysis.
     Value Health Reg Issues. 2023;36:44-50.
     PubMed    
     Abstract available
     
     

121. BARANGA L, Khanuja S, Scott JA, Provancha I, et al
     In Situ Pulmonary Arterial Thrombosis-Literature Review and Clinical Significance of a Distinct Entity.
     AJR Am J Roentgenol. 2023 Mar 1. doi: 10.2214/AJR.23.28996.
     PubMed    
     Abstract available
     
     

122. IANNAZZO F, Pellicano C, Colalillo A, Ramaccini C, et al
     Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement.
     Clin Exp Med. 2023;23:897-903.
     PubMed    
     Abstract available
     
     

123. SANDEEP B, Cheng H, Luo L, Li Y, et al
     Assessing Right Ventricle Pulmonary Artery Coupling and Uncoupling Using Echocardiography and Cardiopulmonary Exercise Test in Post Operative TOF Patients.
     Curr Probl Cardiol. 2023;48:101214.
     PubMed    
     Abstract available
     
     

124. ARRIGO M, Huber LC
     Pulmonary Hypertension in Pulmonary Embolism.
     Am J Cardiol. 2023 Jun 13:S0002-9149(23)00335.
     PubMed    
     
     
     

125. SIMPSON CE, Coursen J, Hsu S, Gough EK, et al
     Metabolic profiling of in vivo right ventricular function and exercise performance in pulmonary arterial hypertension.
     Am J Physiol Lung Cell Mol Physiol. 2023;324:L836-L848.
     PubMed    
     Abstract available
     
     

126. WANG RS, Huang S, Waldo SW, Hess E, et al
     Elevated Pulmonary Arterial Compliance Is Associated with Survival in Pulmonary Hypertension: Results from a Novel Network Medicine Analysis.
     Am J Respir Crit Care Med. 2023 Jun 5. doi: 10.1164/rccm.202211-2097.
     PubMed    
     Abstract available
     
     

127. YANAGIHARA T, Tsubouchi K, Zhou Q, Chong M, et al
     Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
     Am J Respir Crit Care Med. 2023;207:1498-1514.
     PubMed    
     Abstract available
     
     

128. SONNTAG E, Akgun KM, Bag R, Rosensweig EB, et al
     Access to Medically Necessary Reproductive Care for Individuals with Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202302-0230.
     PubMed    
     
     
     

129. MONTANI D, Thore P, Mignard X, Jais X, et al
     Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
     Am J Respir Crit Care Med. 2023 Jun 13. doi: 10.1164/rccm.202210-1941.
     PubMed    
     Abstract available
     
     

130. WEATHERALD J, Zanini U, Humbert M
     Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
     Am J Respir Crit Care Med. 2023 Jun 22. doi: 10.1164/rccm.202306-0990.
     PubMed    
     
     
     

131. MARON BA
     Introducing the Pulmonary Hypertension Thematic Series.
     Am J Respir Crit Care Med. 2023 Jun 21. doi: 10.1164/rccm.202306-1005.
     PubMed    
     
     
     

132. ESTRADA RA
     In symptomatic PAH, adding sotatercept to stable background therapy improved 6-min walk distance at 24 wk.
     Ann Intern Med. 2023;176:JC69.
     PubMed    
     Abstract available
     
     

133. SULLIVAN RT, Austin ED
     Developing a Broader Understanding of Pediatric PAH Worldwide.
     Chest. 2023;163:1353-1355.
     PubMed    
     
     
     

134. QIAN Y, Quan R, Chen X, Gu Q, et al
     Characteristics, Long-term Survival, and Risk Assessment of Pediatric Pulmonary Arterial Hypertension in China: Insights From a National Multicenter Prospective Registry.
     Chest. 2023;163:1531-1542.
     PubMed    
     Abstract available
     
     

135. GONCHAROVA EA, Kudryashova TV, de Jesus Perez VA, Rafikova O, et al
     UnWNTing the Heart: Targeting WNT Signaling in Pulmonary Arterial Hypertension.
     Circ Res. 2023;132:1486-1488.
     PubMed    
     
     
     

136. NAYAKANTI SR, Friedrich A, Sarode P, Jafari L, et al
     Targeting Wnt-ss-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling.
     Circ Res. 2023;132:1468-1485.
     PubMed    
     Abstract available
     
     

137. GUIGNABERT C, Savale L, Boucly A, Thuillet R, et al
     Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.
     Circulation. 2023 Apr 25. doi: 10.1161/CIRCULATIONAHA.122.061501.
     PubMed    
     Abstract available
     
     

138. WATANABE T, Matsuo S, Watanabe Y, Hirama T, et al
     Bilateral Lung Transplant with Pulmonary Artery Reconstruction using Donor Aorta for Pulmonary Hypertension with a Giant Pulmonary Arterial Aneurysm.
     Eur J Cardiothorac Surg. 2023 Jun 19:ezad234. doi: 10.1093.
     PubMed    
     Abstract available
     
     

139. LUIJTEN D, Talerico R, Barco S, Cannegieter SC, et al
     Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: an updated systematic review and meta-analysis.
     Eur Respir J. 2023 Jun 15:2300449. doi: 10.1183/13993003.00449-2023.
     PubMed    
     
     
     

140. GONCHAROVA EA, Kudryashova TV, Pullamsetti SS
     Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"?
     Eur Respir J. 2023;61:2300504.
     PubMed    
     
     
     

141. CHAKRABORTY A, Nathan A, Orcholski M, Agarwal S, et al
     Wnt7a deficit is associated with dysfunctional angiogenesis in pulmonary arterial hypertension.
     Eur Respir J. 2023;61:2201625.
     PubMed    
     Abstract available
     
     

142. WIEDENROTH CB, Guth S
     Response to Huang et al. regarding "Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary hypertension".
     J Heart Lung Transplant. 2023 Jun 20:S1053-2498(23)01908.
     PubMed    
     
     
     

143. XIE F, Quan R, Zhang G, Tian H, et al
     Characteristics, treatments and survival of pulmonary arterial hypertension associated with congenital heart disease in China: Insights from a national multicenter prospective registry.
     J Heart Lung Transplant. 2023;42:974-984.
     PubMed    
     Abstract available
     
     

144. MAI V, Gosselin C, Tremblay E, Rompre G, et al
     Patients' perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.
     Thorax. 2023;78:721-725.
     PubMed    
     Abstract available